drugset / Trial / NCT04993040
A PK Study of Oraxol in Breast Cancer Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, single-arm PK study in approximately 24 breast cancer patients for whom paclitaxel treatment is indicated.
Timeline
- Start
- 2019-04-22
- Primary completion
- 2019-12-09
- Completion
- 2020-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HM30181AK | Unknown | — | — |
| Subject | Paclitaxel | Small molecule | — | Oral |